Cyfra 21-1 and TPA as markers in malignant mesothelioma

被引：0
|
作者：
Bonfrer, JMG
Schouwink, JH
Korse, CM
Baas, P
机构：
[1] OLVG HOSP,DEPT PULMONOL,NL-1091 HA AMSTERDAM,NETHERLANDS
[2] NETHERLANDS CANC INST,ANTONI VAN LEEUWENHOEK HUIS,DEPT MED ONCOL,NL-1066 CX AMSTERDAM,NETHERLANDS
来源：
ANTICANCER RESEARCH | 1997年 / 17卷 / 4B期
关键词：
Cyfra; 21-1; TPA; malignant mesothelioma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma. Materials and Methods: Serum levels of patients were analysed for prognosis of survival and follow up of disease. Results: Cyfra 21-1 and TPA have significant prognostic value for survival. Conclusion: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.
引用
收藏
页码：2971 / 2973
页数：3
相关论文
共 50 条
  • [21] Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma
    Washino, Satoshi
    Hirai, Masaru
    Matsuzaki, Atsushi
    Kobayashi, Yutaka
    UROLOGIA INTERNATIONALIS, 2011, 87 (04) : 420 - 426
  • [22] Clinical significance of CYFRA 21-1 in patients with colorectal cancer
    Sunami, Tomoko
    Kawai, Daisuke
    Takemoto, Koji
    Okanoue, Syotaro
    Yasutomi, Eriko
    Sakaguchi, Chihiro
    Murakami, Mayu
    Oka, Shohei
    Okazaki, Noriko
    Baba, Yuki
    Ishikawa, Hisashi
    Takenaka, Ryuta
    Tsugeno, Hirofumi
    Fujiki, Sigeatsu
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 62 - 62
  • [23] Cytokeratin fragment 19 (CYFRA 21-1) in healthy smokers
    Kao, CH
    Hsieh, JF
    Ho, YJ
    Tsai, SC
    Lee, JK
    ANTICANCER RESEARCH, 1999, 19 (5C) : 4545 - 4546
  • [24] Clinical significance of the tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer
    Kushlinskii, NE
    Lyubimova, NV
    Lemeshko, AO
    Vasilev, AV
    Davydov, MI
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 123 (01) : 85 - 87
  • [25] Diagnostic performance of CTLA-4, carcinoembryonic antigen and CYFRA 21-1 for malignant pleural effusion
    Chen, Mei
    Xie, Shenglong
    Wan, Chun
    Zeng, Ni
    Wu, Yanqiu
    Qin, Jiangyue
    Shen, Yongchun
    Wen, Fuqiang
    POSTGRADUATE MEDICINE, 2017, 129 (06) : 644 - 648
  • [26] Diagnostic value of cyfra 21-1 and carcinoembryonic antigen in differentiation between benign and malignant pleural effusion
    El-Shimy, Waffa S.
    El-Shafey, Basem I.
    El-Sorougy, Hesham A.
    Abd El-Monem, Eman Ali
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2015, 64 (02): : 411 - 417
  • [27] Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions
    Lee, YC
    Knox, BS
    Garrett, JE
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (06): : 765 - 769
  • [28] Role of CYFRA 21-1 and CEA as prognostic and predictive markers in locally advanced and metastatic gastric carcinoma
    Gopal, Vishnu
    Nisha, Yadav
    Ganesan, Prasanth
    Kayal, Smita
    Bobby, Zachariah
    Adithan, Subathra
    Penumadu, Prasanth
    Ramakrishnalay, Vishnu P.
    Bandlamudi, Bhanu P.
    Bahttacharjee, Arnab
    Dahagama, Sindhu
    Dubashi, Biswajit
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (05) : 1412 - 1419
  • [29] Clinical significance of serum CYFRA 21-1 in gastric cancer
    Nakata, B
    Chung, YS
    Kato, Y
    Ogawa, M
    Ogawa, Y
    Inui, A
    Maeda, K
    Sawada, T
    Sowa, M
    BRITISH JOURNAL OF CANCER, 1996, 73 (12) : 1529 - 1532
  • [30] Primary mediastinal choriocarcinoma with elevated serum CYFRA 21-1
    Nakamura H.
    Nakahama H.
    Kitada O.
    Sugita M.
    International Journal of Clinical Oncology, 1999, 4 (5) : 315 - 317
12345